Tirzee (tirzepatide) is a once-weekly dual GIP and GLP-1 receptor agonist injection used to improve blood sugar levels in adults with type 2 diabetes and to support long-term weight management, with dosages ranging from a 2.5 mg initiation dose up to a 15 mg maximum maintenance dose.